Category: Uncategorized
Power and bullying in research
Eric Lander, director of the Office of Science and Technology Policy and science adviser to US President Joe Biden, resigned on Feb […]
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Worldwide, patients with HoFH are diagnosed too late, undertreated, and at high premature ASCVD risk. Greater use of multi-LLT regimens is associated […]
Considerations in boosting COVID-19 vaccine immune responses
A new wave of COVID-19 cases caused by the highly transmissible delta variant is exacerbating the worldwide public health crisis, and has […]
COVID-19 will continue but the end of the pandemic is near
The world is experiencing a huge wave of infection with the omicron variant of SARS-CoV-2. Estimates based on Institute for Health Metrics […]
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
The most recent SARS-CoV-2 variant of concern to emerge has been named omicron.1 Its immune evasion potential was predicted by genomic data […]
Diagnostics for COVID-19: moving from pandemic response to control
Diagnostics have proven to be crucial to the COVID-19 pandemic response. There are three major methods for the detection of SARS-CoV-2 infection […]
UN sanctions hamper humanitarian work
Aid leaders have warned that unintended consequences of UN sanctions are a growing problem for humanitarian actors and have called for more […]
Antimicrobial resistance: time to repurpose the Global Fund
Antimicrobial resistance (AMR) is a major cause of death globally, with a burden likely to be higher than that of HIV or […]
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
We found progressively waning vaccine effectiveness against SARS-CoV-2 infection of any severity across all subgroups, but the rate of waning differed according […]